GlassScriptPhysician profile
Anusha Mithani
NPI 1548985849
$1,727.54
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,688 · Education: $39.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,688.18 |
| Education | $39.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $685.02 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $254.33 | 2024 | Dupixent |
| Madrigal Pharmaceuticals | $190.83 | 2024 | Rezdiffra, Resmetirom |
| Takeda Pharmaceuticals U.S.A., INC. | $162.75 | 2024 | Entyvio |
| Genzyme Corporation | $87.77 | 2024 | |
| Phathom Pharmaceuticals, INC. | $66.39 | 2024 | Voquezna |
| Celltrion USA INC. | $39.36 | 2024 | Zymfentra |
| Pfizer INC. | $35.91 | 2024 | |
| Janssen Biotech, INC. | $35.38 | 2024 | Tremfya |
| Braintree Laboratories, INC. | $24.50 | 2024 | Suflave, Sutab |
| Lilly USA, LLC | $23.65 | 2024 | Omvoh |
| Ardelyx, INC. | $22.31 | 2024 | Ibsrela |
| Qol Medical, LLC | $21.42 | 2024 | Sucraid |
| Fresenius Kabi USA, LLC | $17.77 | 2024 | Idacio |
| Vivus LLC | $16.90 | 2024 | Qsymia |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $16.28 | 2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.82 | 2024 | Xifaxan |
| Intercept Pharmaceuticals, INC. | $13.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anusha Mithani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.